Image Results
No matches found.
Video Results
No matches found.
Web Results
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | Next | Last
Artemis -- July 2008 (Search Map)
Eribulin Mesylate Demonstrates Anti-Tumor Activity in Patients with Advanced ... chemotherapeutic agent eribulin mesylate (E7389) demonstrated activity in a ...
Eribulin mesylate demonstrated anti-tumor activity in patients with ... (Search Map)
The investigational chemotherapeutic agent eribulin mesylate (E7389) demonstrated activity in a heavily pretreated population of women with locally advanced or ...
FOR IMMEDIATE RELEASE February 1, 2008 Eisai Co., Ltd. Eisai ... (Search Map)
(NDA) for E7389 (generic name: eribulin mesylate) for third-line ... Eisai is committed to developing E7389 as a potential treatment for patients with advanced ...
Feb. 6, 2008 (Search Map)
Home > Newsletters > RxTrials Institute Drug Pipeline Alert > Archives > Feb. 6, 2008 ... E7389 for third-line treatment of advanced breast cancer patients who were ...
Senate resolution shines spotlight on the importanc... ( WASHINGTON DC ... (Search Map)
...WASHINGTON DC JULY 7 2008 -- The Soil Science Society of America (S...On June ... Eisai announces Phase II data on E7389, a potential new therapy for the ...
Eribulin Mesylate Has Significant Activity in Refractory Breast Cancer ... (Search Map)
A multi-institutional Phase II study has determined that eribulin mesylate (E7389, NSC 707389), a microtubule inhibitor, has significant activity in women with ...
Marine life: New hope for cancer drugs Jain R - Indian J Cancer (Search Map)
The Indian Journal of Cancer is an official publication of the Indian Cancer Society and ... Dolastatin-10, Discodermolide, Eleutherobin, E7389, Girolline, ...
Drugs.com - Pharma Industry News Archive February 2008 (Search Map)
Drugs.com pharma industry news archive. Comprehensive drug news for both ... Eisai Announces Change in U.S. Submission Schedule for E7389 New Drug Application ...
E7389 in Treating Patients With Metastatic Prostate Cancer That Did Not ... (Search Map)
A Phase II Trial of E7389 (Halichondrin B Analog), in Patients With Metastatic ... Patients receive E7389 IV over 5 minutes on days 1 and 8. Courses repeat every ...
A Study of E7389 in Advanced/Metastatic Breast Cancer Patients - Full ... (Search Map)
The safety and tolerability of E7389 monotherapy in this patient population; The antitumor activity of E7389 as determined by duration of response, time to ...